课题基金 / 基金详情

Investigation of Parkinson's disease causing substances

Investigation of Parkinson's disease causing substances
帕金森病致病物质的调查
批准号:
10470495
负责人:
OHTA Shigeru
金额:
$0.96万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 1999

项目摘要

项目成果

OHTA Shigeru的其他基金

相似基金

相关文献

中文摘要
翻译
1,2,3,4-四氢异喹啉(TIQ)类化合物存在于哺乳动物体内,其化学结构类似于MPTP,已被认为是内源性帕金森病致病化合物的候选化合物。最近有报道称,1-苄基-1,2,3,4-四氢异喹啉(1BnTIQ)存在于人脑脊液和小鼠脑中,并提出1BnTIQ是由2-苯乙胺和苯乙醛生物合成的,苯乙醛是由B型一氧化氮合酶生成的2-苯乙胺的代谢产物。PD患者脑脊液中的1BnTIQ含量高于其他神经系统疾病患者。此外,反复服用这种化合物会导致猴子和小鼠患上帕金森症。1BnTIQ可通过多巴胺转运体(DAT)抑制HEK293细胞对多巴胺的摄取,提示1BnTIQ通过DAT以1-甲基-4-苯基吡啶离子的形式被摄取,1-甲基-4-苯基吡啶是多巴胺能神经毒素MPTP的活性代谢产物。我们还报道了包括1BnTIQ在内的各种四氢异喹啉衍生物抑制线粒体呼吸和电子传递复合体的作用。
英文摘要
1, 2, 3, 4-Tetrahydroisoqpinoline (TIQ) derivatives, which chemically resemble MPTP, exist in mammals and have been proposed as candidates for endogenous parkinsonogenic compounds.It was recently reported 1-benzyl-1, 2, 3, 4-tetrahydroisoqpinoline (1BnTIQ) is present in human cerebrospinal fluid and mouse brain, and proposed that 1BnTIQ is biosynthesized from 2-phenylethylamine and phenylacetaldehyde which is a metabolite of 2-pherrylethylamine generated by monoanrine oxidase-type B. The 1BnTIQ content in cerebrospinal fluid of patients with PD is higher than that of patients with other neurological diseases. Further, repeated administration of this compound induced parkinsonism in the monkey and mouse. 1BnTIQ inhibited dopamine uptake through dopamine transporter (DAT) expressed in HEK293 cells, suggesting that 1BnTIQ is uptaken through DAT as 1-methyl-4-phenylpyridinium ion, which is an active metabolite of dopaminergic neurotoxin, MPTP. We also reported that various tetrahydroisoquinoline derivatives including 1BnTIQ inhibited mitochondrial respiration and the electron transfer complexes.
期刊论文(34)
专著(0)
科研奖励(0)
会议论文
K.Matsubara: "Sturactural significance of azaheterocyclic amines related to Parkinson's disease from dopamine transporter"Eur.J.Pharmacol.. 348. 77-84 (1998)
K.Matsubara:“多巴胺转运蛋白与帕金森病相关的氮杂环胺的结构意义”Eur.J.Pharmacol.. 348. 77-84 (1998)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
T. Yamakawa, Y. Kotake, M. Fujitani, H. Shintani, Y. Makino, S. Ohta: "Regional distribution of parkinsonism-preventing endogenous tetrahydroisoquinoline derivatives and an endogenous parkinsonism-preventing substance-synthesizing enzyme in monkey brain."
T. Yamakawa、Y. Kotake、M. Fujitani、H. Shintani、Y. Makino、S. Ohta:“猴脑中预防帕金森病的内源性四氢异喹啉衍生物和内源性帕金森病预防物质合成酶的区域分布。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Y.Kotake: "Deprenyl decreases an endogenous parkinsonisum-inducing compound,1-benzyl-1,2,3,4-tetrahydroisoquinoline in mice in vivo and in vitro studies"Brain Res.. 787. 341-343 (1998)
Y.Kotake:“Deprenyl 减少了小鼠体内和体外研究中的内源性帕金森病诱导化合物 1-benzyl-1,2,3,4-四氢异喹啉”Brain Res.. 787. 341-343 (1998)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
T.Yamalawa: "Biosynthesis of a parkinsonism-preventing substance,1-methy-1,2,3,4-tetrahydroisoquinoline,is inhibited by parkinsonism-inducing compunds"Neurosci. lett.. 259. 157-167 (1999)
T.Yamalawa:“帕金森病预防物质 1-甲基-1,2,3,4-四氢异喹啉的生物合成受到帕金森病诱导化合物的抑制”Neurosci。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 32 条
    Toxicities and pharmacokinetics of new chemical structures of designer drugs, and their prediction in humans
    • 批准号:
      18H03066
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.15万
    • 财政年份:
      2018
    • 负责人:
      OHTA Shigeru
    • 依托单位:
    Prediction of interindividual differences of drug metabolism and pharmacokinetics using chimeric mice with humanized liver
    • 批准号:
      23659053
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.41万
    • 财政年份:
      2011
    • 负责人:
      OHTA Shigeru
    • 依托单位:
    Pathogenetic mechanism of sporadic Parkinson's disease based on familial Parkinson's disease
    • 批准号:
      20390040
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.81万
    • 财政年份:
      2008
    • 负责人:
      OHTA Shigeru
    • 依托单位:
    Drug development using novel animal model based on the pathogenesis of Parkinson' s disease-related disorders
    • 批准号:
      20406005
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $10.32万
    • 财政年份:
      2008
    • 负责人:
      OHTA Shigeru
    • 依托单位:
    海外基金